Driven by discoveries of the molecular causes of cancer and revolutionary therapies, such as immunotherapy, the transformation of many cancer types into chronic, manageable diseases will become a reality during the next few decades. Despite headlines about precision and personalized medicine with
Beyond the moonshot: Achieving universal cancer care
The accelerating pace of scientific breakthroughs in medical science, bioinformatics, and digital healthcare captivates the world’s imagination. Advances that took years to achieve can be now be realized in days or mere hours. President John Kennedy’s moonshot mission in the 1960s that landed a man
FDA hold on guidance for laboratory developed tests is a wise action
On Nov. 18, the Food and Drug Administration (FDA) announced that an oversight policy regulating laboratory developed tests (LDTs) will be put on hold. The agency will reconsider this guidance in discussions with the new administration, Congress and stakeholders. This is good news for those
This is personal: Less chemotherapy for breast cancer
A close relative was diagnosed of invasive breast cancer five years ago. After surgery she received chemotherapy and did well, today she is in remission. Would she still be in remission without chemotherapy? In patients with breast cancer, oncologists are always confronted with a crucial question: